Cytosorbents Corporation (CTSO) Financials

CTSO Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 53.3 million 30.0 million
2023-09-30 47.6 million 29.1 million
2023-06-30 52.4 million 28.4 million
2023-03-31 57.5 million 28.5 million

CTSO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.5 million 1.1 million
2023-09-30 -5.5 million 1.4 million
2023-06-30 -6.7 million 214542
2023-03-31 -3.8 million 1.1 million

CTSO Net Income

No data available :(

CTSO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 14.1 million - 13.3 million
2023-09-30 8.4 million - 13.0 million
2023-06-30 13.2 million - 13.1 million
2023-03-31 19.0 million - 13.2 million

CTSO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 48.6 million
2023-09-30 44.4 million
2023-06-30 44.0 million
2023-03-31 43.7 million

CTSO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 135922 4.1 million 10.6 million -1.3 million
2023-09-30 257715 3.7 million 9.2 million -
2023-06-30 209448 3.7 million 8.9 million 38000
2023-03-31 682884 4.2 million 9.1 million 55000

CTSO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 8.7 million 3.4 million
2023-09-30 7.8 million 3.2 million
2023-06-30 8.1 million 3.4 million
2023-03-31 7.9 million 4.0 million

CTSO

Price: $0.88

52 week price:
0.79
4.29

Earnings Per Share: -0.64 USD

P/E Ratio: -1.92

Exchange: NCM

Sector: Healthcare

Industry: Medical Devices

Volume: 305200

Ebitda: -2.1 million

Market Capitalization: 54.1 million

Links: